The Latest Breaking News from FDA

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Detecting cancer early before it spreads throughout the body can be lifesaving. This is why doctors recommend regular screening for several common cancer types, using a variety of methods. Colonoscopies, for example, screen for colon cancer, while mammograms screen for breast cancer.

A breast ultrasound, sometimes called a sonogram, uses sound waves to take images of the breast tissue

Walt Bogdanich and Michael Forsythe of the New York Times have done their homework on the management giant

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.

One of the biggest beneficiaries of the governor's pandemic and Operation Lone Star disaster declarations has now kicked Abbott a cool $150,000.

The treat known as Dragon's Breath, a liquid nitrogen-based sweet, should be treated with caution as it can potentially cause frostbite, Thailand's Food and Drug Administration (FDA) has warned.

The U.S. Food and Drug Administration is set to review a drugmaker’s application for the first over-the-counter birth control pill in November 2022, with a decision expected in the first half of 2023.

The FDA delayed the delivery of 1 million vaccine doses, and many high-risk Americans were turned away from health clinics that had run out of vaccines.

The medical cannabis industry in Utah is confusing since synthetic cannabinoid-laden products appeared in naturally abundant amounts on dispensary shelves. According to the FDA, CBD is synthesized from delta-8, THC and a variety of other cannabinoids that could pose "serious health risks."

WASHINGTON — The Food and Drug Administration on Wednesday postponed a critical advisory meeting on an application for the nation’s first over-the-counter birth control pill, citing the need “to review new information.”